These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31698798)
1. CDK5: Key Regulator of Apoptosis and Cell Survival. Roufayel R; Murshid N Biomedicines; 2019 Nov; 7(4):. PubMed ID: 31698798 [TBL] [Abstract][Full Text] [Related]
2. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Hisanaga S; Saito T Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209 [TBL] [Abstract][Full Text] [Related]
3. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators. Saito T; Yano M; Kawai Y; Asada A; Wada M; Doi H; Hisanaga SI J Biol Chem; 2013 Nov; 288(45):32433-32439. PubMed ID: 24085300 [TBL] [Abstract][Full Text] [Related]
4. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors. Schmid G; Strosznajder JB; Wesierska-Gadek J Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520 [TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. Amin ND; Albers W; Pant HC J Neurosci Res; 2002 Feb; 67(3):354-62. PubMed ID: 11813240 [TBL] [Abstract][Full Text] [Related]
6. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses. Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner. Asada A; Saito T; Hisanaga S J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861 [TBL] [Abstract][Full Text] [Related]
8. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35. Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264 [TBL] [Abstract][Full Text] [Related]
10. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541 [TBL] [Abstract][Full Text] [Related]
11. Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes. Asada A; Yamamoto N; Gohda M; Saito T; Hayashi N; Hisanaga S J Neurochem; 2008 Aug; 106(3):1325-36. PubMed ID: 18507738 [TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses. Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038 [TBL] [Abstract][Full Text] [Related]
13. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357 [TBL] [Abstract][Full Text] [Related]
14. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35. Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551 [TBL] [Abstract][Full Text] [Related]
15. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424 [TBL] [Abstract][Full Text] [Related]
16. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Maccioni RB; Otth C; Concha II; Muñoz JP Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668 [TBL] [Abstract][Full Text] [Related]
17. Cyclin I and p35 determine the subcellular distribution of Cdk5. Hagmann H; Taniguchi Y; Pippin JW; Kauerz HM; Benzing T; Shankland SJ; Brinkkoetter PT Am J Physiol Cell Physiol; 2015 Feb; 308(4):C339-47. PubMed ID: 25500740 [TBL] [Abstract][Full Text] [Related]
18. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. Zheng M; Leung CL; Liem RK J Neurobiol; 1998 May; 35(2):141-59. PubMed ID: 9581970 [TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. Li BS; Zhang L; Takahashi S; Ma W; Jaffe H; Kulkarni AB; Pant HC EMBO J; 2002 Feb; 21(3):324-33. PubMed ID: 11823425 [TBL] [Abstract][Full Text] [Related]
20. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia. Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]